Nom du produit:L-lysine compound with 2-((1-benzyl-1H-indazol-3-yl)oxy)acetic acid (1:1)

IUPAC Name:(2S)-2,6-diaminohexanoic acid; 2-[(1-benzyl-1H-indazol-3-yl)oxy]acetic acid

CAS:81919-14-4
Formule moléculaire:C22H28N4O5
Pureté:98%
Numéro de catalogue:CM149971
Poids moléculaire:428.49

Unité d'emballage Stock disponible Prix($) Quantité
CM149971-25g 1-2 Weeks Ŕƻň
CM149971-100g 1-2 Weeks ňŭƻ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:81919-14-4
Formule moléculaire:C22H28N4O5
Point de fusion:-
Code SMILES:O=C(O)[C@@H](N)CCCCN.O=C(O)COC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
Densité:
Numéro de catalogue:CM149971
Poids moléculaire:428.49
Point d'ébullition:698.4°C at 760 mmHg
N° Mdl:MFCD07776898
Stockage:Store at 2-8°C.

Category Infos

Indazoles
Indazoles are a class of organic heterocyclic compounds, also known as 1,2-diazaindene and benzopyrazole. Indazole is a good bioisomer of phenol, which is more lipophilic than phenol and less prone to phase I and II metabolism. Indazole derivatives have a wide range of biological activities, and it has been confirmed that indazole compounds have anti-tumor, analgesic, anti-inflammatory and other drug activities. Anticancer is the most important application field of indazole drugs. Renal cell carcinoma, solid tumor, nausea and vomiting caused by chemotherapy and leukemia are the main indications of this structural backbone drug.

Column Infos